Philippe Laffont’s Medtronic MDT Stock Holding History

Philippe Laffont’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,055	Closed	-$687K	–	299
2019 Q4	$687K	Buy	+6,055	New	+$664K	0.01%	166

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Philippe Laffont's MDT Position: Q1 2020 in Review

Philippe Laffont sold out of Medtronic (MDT) in Q1 2020, closing a stake of 6,055 shares — an estimated $687K sold.

Philippe Laffont first reported a position in MDT in Q4 2019 and held it in 1 quarter. The position peaked at $687K in Q4 2019. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

Philippe Laffont reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
Philippe Laffont sold 6,055 Medtronic shares in Q1 2020, an estimated $687K.
Philippe Laffont first reported a position in Medtronic in Q4 2019 and held it in 1 quarter.
Philippe Laffont's Medtronic position peaked at $687K in Q4 2019.
1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Coatue Management's 13F filing for Q1 2020, filed 15 May 2020.